Key Drivers Shaping the Spain Radiopharmaceuticals Market
The Spain Radiopharmaceuticals Market growth continues to accelerate as radioembolisation with Yttrium-90 microspheres establishes itself as a standard treatment for primary and metastatic liver tumours. With hepatocellular carcinoma incidence rising in Spain linked to hepatitis C history and metabolic liver disease, and with colorectal cancer liver metastases representing a major oncological...
0 Комментарии 0 Поделились 170 Просмотры 0 предпросмотр